Recon: FDA mulls second COVID booster; GSK pauses some RSV vax trials
ReconDenise Fulton
BiologicsBiotechnologyCombination ProductsDiagnosticsGlobalMedical DevicesOTCPharmaceuticalsReconDenise FultonBiologicsBiotechnologyCombination ProductsDiagnosticsGlobalMedical DevicesOTCPharmaceuticals